1,720,974 research outputs found
Author_response_v.2 – Supplemental material for Practical management of riociguat in patients with pulmonary arterial hypertension
Supplemental material, Author_response_v.2 for Practical management of riociguat in patients with pulmonary arterial hypertension by Michael Halank, Kristin Tausche, Ekkehard Grünig, Ralf Ewert and Ioana R. Preston in Therapeutic Advances in Respiratory Disease</p
Reviewer_3_v.3 – Supplemental material for Practical management of riociguat in patients with pulmonary arterial hypertension
Supplemental material, Reviewer_3_v.3 for Practical management of riociguat in patients with pulmonary arterial hypertension by Michael Halank, Kristin Tausche, Ekkehard Grünig, Ralf Ewert and Ioana R. Preston in Therapeutic Advances in Respiratory Disease</p
Reviewer_3_v.2 – Supplemental material for Practical management of riociguat in patients with pulmonary arterial hypertension
Supplemental material, Reviewer_3_v.2 for Practical management of riociguat in patients with pulmonary arterial hypertension by Michael Halank, Kristin Tausche, Ekkehard Grünig, Ralf Ewert and Ioana R. Preston in Therapeutic Advances in Respiratory Disease</p
Reviewer_1_v.1 – Supplemental material for Practical management of riociguat in patients with pulmonary arterial hypertension
Supplemental material, Reviewer_1_v.1 for Practical management of riociguat in patients with pulmonary arterial hypertension by Michael Halank, Kristin Tausche, Ekkehard Grünig, Ralf Ewert and Ioana R. Preston in Therapeutic Advances in Respiratory Disease</p
Reviewer_2_v.1 – Supplemental material for Practical management of riociguat in patients with pulmonary arterial hypertension
Supplemental material, Reviewer_2_v.1 for Practical management of riociguat in patients with pulmonary arterial hypertension by Michael Halank, Kristin Tausche, Ekkehard Grünig, Ralf Ewert and Ioana R. Preston in Therapeutic Advances in Respiratory Disease</p
Reviewer_3_v.1 – Supplemental material for Practical management of riociguat in patients with pulmonary arterial hypertension
Supplemental material, Reviewer_3_v.1 for Practical management of riociguat in patients with pulmonary arterial hypertension by Michael Halank, Kristin Tausche, Ekkehard Grünig, Ralf Ewert and Ioana R. Preston in Therapeutic Advances in Respiratory Disease</p
Author_response_v.1 – Supplemental material for Practical management of riociguat in patients with pulmonary arterial hypertension
Supplemental material, Author_response_v.1 for Practical management of riociguat in patients with pulmonary arterial hypertension by Michael Halank, Kristin Tausche, Ekkehard Grünig, Ralf Ewert and Ioana R. Preston in Therapeutic Advances in Respiratory Disease</p
Supplemental material for Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1/-2 studies
Supplemental material for Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1/-2 studies by Rodrigo Cartin-Ceba, Michael Halank, Hossein-Ardeschir Ghofrani, Marc Humbert, John Mattson, Arno Fritsch and Michael Krowka in Pulmonary Circulation</p
Going Beyond Counting First Authors in Author Co-citation Analysis
The present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
- …
